AOD-9604 vs GLP-3 RT GLP-3 RT (retatrutide) adds a third receptor target glucagon on top of the GIP/GLP-1 combination, representing the broadest incretin-pathway approach among compounds referenced in this comparison
Some people, particularly those who were severely deficient, report a sudden improvement in energy, focus, or mood within 24 to 72 hours
Inject slowly
Exercise caution or avoid with: Ready to put this into practice
Healthcare professionals who encounter patients using unlicensed peptides should approach the conversation without judgement, document use carefully, and consider appropriate baseline investigations including liver function tests, lipid profile, and renal function
By contrast, MIC blends used for weight loss are compounded formulas (ingredients and doses vary by clinic) and are not FDA-approved as weight-loss drugs